As you read this try not to get defensive. When it comes to Syneos, Gsk reps have one of two things going on. They either allow their egos to blind them or they have their heads wedged between their a$$ cheeks. Either way they can't read the writing on the wall. The fact that Syneos is a part of out team clearly demonstrates that it's just a matter of time. How many competitors are on the market now? How many specialties do we call on? How many of our competitors have contracted sales teams? The fact of the matter is, 2023 will be the end of GSK as we know it. Those Syneos reps that you hold such distain for may be you very soon. Now everyone, let's COCO!!!